Weight Changes After Breast Cancer: What We Know About GLP-1 Medications
Wed, Jul 22
|Zoom
Are these medications safe and effective for people diagnosed with breast cancer?Learn how breast cancer treatment affects weight, metabolism, and survivorship, and what current research says about GLP-1 medications like Ozempic and Wegovy.
Time & Location
Jul 22, 2026, 6:00 PM – 7:00 PM EDT
Zoom
About the event
Breast cancer treatment can bring many unexpected challenges. Many people experience weight gain related to chemotherapy, steroids, menopause, endocrine therapy, fatigue, changes in appetite, and the emotional toll of a breast cancer diagnosis and treatment. At the same time, medications known as GLP-1 receptor agonists—including Ozempic, Wegovy, Mounjaro, and Zepbound—are receiving growing attention for their role in diabetes care, weight management, and potentially cancer-related outcomes.
Join SurvivingBreastCancer.org for an informative and patient-centered webinar with Dr. Sherry Shen, breast medical oncologist at Memorial Sloan Kettering Cancer Center, whose research focuses on breast cancer, metabolism, lifestyle, and weight management during and after treatment.
Dr. Shen will help us understand why people diagnosed with breast cancer are prone to gaining weight, what GLP-1 medications are, what current research does and does not show for people diagnosed with breast cancer, and why weight and metabolic health are important parts of breast cancer survivorship care.
She…